Design Therapeutics, Inc.Design Therapeutics, Inc.Design Therapeutics, Inc.

Design Therapeutics, Inc.

No trades
See on Supercharts

DSGN fundamentals

An in-depth look to Design Therapeutics, Inc. operating, investing, and financing activities

DSGN free cash flow for Q3 24 is -9.53 M USD. For 2023, DSGN free cash flow was -58.82 M USD and operating cash flow was -58.56 M USD.

Q1 '20
Q2 '20
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth